Generic name: Flibanserin 100mg
Dosage form: tablet, film coated
Medically reviewed on August 17, 2018.
The recommended dosage of ADDYI is 100 mg administered orally once per day at bedtime. ADDYI is dosed at bedtime because administration during waking hours increases the risks of hypotension, syncope, accidental injury, and central nervous system (CNS) depression (such as somnolence and sedation).
If a dose of ADDYI is missed at bedtime, instruct the patient to take the next dose at bedtime on the next day. Instruct the patient to not double the next dose.
Discontinuation of ADDYI
Discontinue ADDYI after 8 weeks if the patient does not report an improvement in her symptoms.
Initiation of ADDYI Following Moderate or Strong CYP3A4 Inhibitor Use
If initiating ADDYI following moderate or strong CYP3A4 inhibitor use, start ADDYI 2 weeks after the last dose of the CYP3A4 inhibitor.
If initiating a moderate or strong CYP3A4 inhibitor following ADDYI use, start the moderate or strong CYP3A4 inhibitor 2 days after the last dose of ADDYI [see Warnings and Precautions (5.3)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Addyi (flibanserin)
- Addyi Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 7 Reviews
- Drug class: miscellaneous central nervous system agents